Breast Cancer Treatment

Breast cancer is one of the most common malignant tumors in women, mainly affecting those over 40, though in recent years the incidence has shown a younger trend. Treatment methods are diverse, including local surgery and systemic therapies. If intervention is delayed, tumors may metastasize to bones, lungs, and other organs, affecting survival and quality of life. Therefore, selecting appropriate treatment requires comprehensive judgment based on pathology, staging, and individual patient factors.

Emerging Treatments

Immune Reconstruction Cell Therapy

Immune reconstruction cell therapy is an innovative approach that has gained much attention in recent years. It enhances anti-tumor immunity and reduces recurrence. By collecting a patient’s immune cells, expanding and activating them in vitro, and reinfusing them back into the body, this therapy rebuilds immune recognition and killing mechanisms. It holds promise as an important adjunct in long-term management of breast cancer.

① Effectively eliminates residual cancer cells, reducing recurrence;

② Suitable for hormone receptor-negative or drug-resistant breast cancer patients;

③ Enhances overall efficacy when combined with other therapies;

④ Has relatively low side effects, suitable for elderly and postoperative frail patients;

⑤ Useful for maintenance therapy and long-term management, delaying disease progression.

In clinical practice, breast cancer patients undergoing surgery, radiotherapy, or chemotherapy often face impaired immunity, higher infection risks, and slow recovery. To support patients through treatment and improve tolerance and quality of survival, immune reconstruction plans must be scientifically designed in stages for different treatment cycles.

● Short-term Plan: Rapidly boost immunity through immune cell reinfusion, enhancing anti-tumor treatment effects.

● Mid-term Plan: Reduce side effects of conventional therapy, promote recovery, and ensure completion of standard regimens.

● Long-term Plan: Enhance immunity comprehensively through immune cell, intestinal, elemental, and nutritional reconstruction, thereby improving quality of life and prolonging survival.

Conventional Treatments

1. Surgery

Surgery remains the first-line option for early breast cancer, typically including breast-conserving surgery (lumpectomy) or mastectomy. The choice depends on tumor size, location, and patient preference. Postoperative radiotherapy and systemic therapy may be added to reduce local recurrence risks.

3. Radiotherapy

Radiotherapy is often used postoperatively to eliminate microscopic residual lesions, particularly in breast-conserving patients. Modern precision techniques such as Intensity-Modulated Radiotherapy (IMRT) improve safety and efficacy.

4. Chemotherapy

Chemotherapy is suitable for advanced breast cancer, especially lymph node-positive or hormone receptor-negative patients. Typical cycles last 3–6 months, with drugs like doxorubicin and paclitaxel commonly used. While effective in controlling systemic micrometastasis, it requires careful monitoring of bone marrow, liver, and kidney function.

5. Targeted and Endocrine Therapy

Targeted therapy is used for HER2-positive breast cancer, with drugs such as trastuzumab significantly improving survival. Hormone receptor-positive patients benefit from long-term endocrine therapy with drugs like tamoxifen or aromatase inhibitors. These have fewer side effects, making them suitable for maintenance treatment.

6. Radiofrequency Ablation

Uses high-frequency currents to generate heat, leading to tumor coagulation and necrosis.

7. Cryoablation

Uses cryogenic agents such as liquid nitrogen or argon to destroy tumor cells through freeze-thaw cycles.

8. Microwave Ablation

Uses microwave energy to heat tissues, causing coagulative necrosis. This method provides faster heating and wider coverage.

Conclusion

Breast cancer treatment requires comprehensive evaluation based on molecular subtype and individual conditions. Experts at United Life International Medical Center emphasize that immune reconstruction cell therapy offers new hope for patients undergoing multiple lines of treatment. On top of standard care, integrating advanced approaches can optimize outcomes.